They further elucidated that METTL3 inhibited proliferation and metastasis in renal cell carcinoma via epithelial‐to‐mesenchymal transition (EMT) and PI3K‐Akt‐mTOR pathways. This evidence concerns the gene METTL3 and renal cell carcinoma.